Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma

Journal of Cutaneous Pathology

Volumn 34, Issue 10, 2007, Pages 782-787

  Krahl, Dieter ^a   Sellheyer, Klaus ^b  

^a Institut fur Dermatohistologie   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER EP4; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CELL INFILTRATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROCYSTIC ADNEXAL CARCINOMA; SCLERODERMA; SKIN BIOPSY; SKIN CARCINOMA; TRICHOEPITHELIOMA;

BIOPSY; CARCINOMA, BASAL CELL; CARCINOMA, SKIN APPENDAGE; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; SCLEROSIS; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34648822542     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00710.x     Document Type: Article

References (40)

1. Fernandez EM, Helm T, Ioffreda M, Helm KF. The vanishing biopsy: the trend toward smaller specimens. Cutis 2005 76 : 335.
2. Hamm JC, Argenta LC, Swanson NA. Microcystic adnexal carcinoma: an unpredictable aggressive neoplasm. Ann Plast Surg 1987 19 : 173.
3. Chiller K, Passaro D, Scheuller M, Singer M, McCalmont T, Grekin RC. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000 136 : 1355.
4. Salerno S, Terrill P. Will MAC be back? ANZ J Surg 2003 73 : 830.
5. Stein JM, Ormsby A, Esclamado R, Bailin P. The effect of radiation therapy on microcystic adnexal carcinoma: a case report. Head Neck 2003 25 : 251.
6. Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000 22 : 123.
7. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 1990 43 : 213.
8. Tellechea O, Reis JP, Domingues JC, Baptista AP. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 1993 15 : 452.
9. Jones MS, Helm KF, Maloney ME. The immunohistochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg 1997 23 : 181.
10. Beer TW, Shepherd P, Theaker JM. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 2000 37 : 218.
11. Rossen K, Thomsen HK. Ber-EP4 immunoreactivity depends on the germ layer origin and maturity of the squamous epithelium. Histopathology 2001 39 : 386.
12. Mitsuhashi T, Itoh T, Shimizu Y et al. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants. J Cutan Pathol 2006 33 : 246.
13. Alvarez-Canas MC, Fernandez FA, Rodilla IG, Val-Bernal JF. Perianal basal cell carcinoma: a comparative histologic, immunohistochemical, and flow cytometric study with basaloid carcinoma of the anus. Am J Dermatopathol 1996 18 : 371.
14. Hayden AA, Shamma HN. Ber-EP4 and MNF-116 in a previously undescribed morphologic pattern of granular basal cell carcinoma. Am J Dermatopathol 2001 23 : 530.
15. Dundr P, Stork J, Povysil C, Vosmik F. Granular cell basal cell carcinoma. Australas J Dermatol 2004 45 : 70.
16. Kist D, Perkins W, Christ S, Zachary CB. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation. Dermatol Surg 1997 23 : 1067.
17. Saladi RN, Singh F, Wei H, Lebwohl MG, Phelps RG. Use of Ber-EP4 protein in recurrent metastatic basal cell carcinoma: a case report and review of the literature. Int J Dermatol 2004 43 : 600.
18. Del Rosario RN, Barr RJ, Jensen JL, Cantos KA. Basal cell carcinoma of the buccal mucosa. Am J Dermatopathol 2001 23 : 203.
19. Billingsley EM, Fedok F, Maloney ME. Microcystic adnexal carcinoma. Case report and review of the literature. Arch Otolaryngol Head Neck Surg 1996 122 : 179.
20. Jimenez FJ, Burchette JL Jr., Grichnik JM, Hitchcock MG. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 1995 8 : 854.
21. Smith KJ, Williams J, Corbett D, Skelton H. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol 2001 25 : 464.
22. Matsuki T, Hayashi N, Mizushima J, Igarashi A, Kawashima M, Harada S. Two cases of desmoplastic trichoepithelioma. J Dermatol 2004 31 : 824.
23. Friedman PM, Friedman RH, Jiang SB, Nouri K, Amonette R, Robins P. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol 1999 41 : 225.
24. Swanson PE, Fitzpatrick MM, Ritter JH, Glusac EJ, Wick MR. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol 1998 25 : 153.
25. Abesamis-Cubillan E, El-Shabrawi-Caelen L, LeBoit PE. Merkel cells and sclerosing epithelial neoplasms. Am J Dermatopathol 2000 22 : 311.
26. LeBoit PE, Sexton M. Microcystic adnexal carcinoma of the skin. A reappraisal of the differentiation and differential diagnosis of an underrecognized neoplasm. J Am Acad Dermatol 1993 29 : 609.
27. Ongenae KC, Verhaegh ME, Vermeulen AH, Naeyaert JM. Microcystic adnexal carcinoma: an uncommon tumor with debatable origin. Dermatol Surg 2001 27 : 979.
28. Abbate M, Zeitouni NC, Seyler M, Hicks W, Loree T, Cheney RT. Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg 2003 29 : 1035.
29. Clement CI, Genge J, O'Donnell BA, Lochhead AG. Orbital and periorbital microcystic adnexal carcinoma. Ophthal Plast Reconstr Surg 2005 21 : 97.
30. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer 1982 50 : 566.
31. Apisarnthanarax P, Bovenmyer DA, Mehregan AH. Combined adnexal tumor of the skin. Arch Dermatol 1984 120 : 231.
32. Nickoloff BJ, Fleischmann HE, Carmel J, Wood CC, Roth RJ. Microcystic adnexal carcinoma. Immunohistologic observations suggesting dual (pilar and eccrine) differentiation. Arch Dermatol 1986 122 : 290.
33. Wick MR, Cooper PH, Swanson PE, Kaye VN, Sun TT. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors. Arch Dermatol 1990 126 : 189.
34. Cooper PH, Mills SE, Leonard DD, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol 1985 9 : 422.
35. Abenoza P, Ackerman AB. Syringomatous carcinomas. In Abenoza P, Ackerman AB, eds. Neoplasms with eccrine differentiation, 1st ed. Philadelphia, London : Lea & Febiger, 1990 373.
36. Requena L, Marquina A, Alegre V, Aliaga A, Sanchez Yus E. Sclerosing-sweat-duct (microcystic adnexal) carcinoma - a tumor from a single eccrine origin. Clin Exp Dermatol 1990 15 : 222.
37. Ackerman AB, Briggs PL, Bravo F. Differential Diagnosis in Dermatopathology III, 1st ed. Philadelphia, London : Lea & Febiger, 1993 86.
38. McCalmont TH. A call for logic in the classification of adnexal neoplasms. Am J Dermatopathol 1996 18 : 103.
39. Santa Cruz DJ. Tumors of sweat gland differentiation. In Farmer ER, Hood AF, eds. Pathology of the skin. Norwalk : Appleton & Lange, 1990 624.
40. Pujol RM, LeBoit PE, Su WP. Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol 1997 19 : 358.